Peer-reviewed articleOpen access

Characteristics of Esketamine Prescribers Among Medicare Beneficiaries in the United States, 2019-2020.

Havlik JL, Murphy MJ iD, Gong N iD, Tang D, Krystal JH

JAMA network openApr 3, 2023License: open access4 citationsDOI: 10.1001/jamanetworkopen.2023.11250

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021

ArticleKetamine

Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.

Guellim S, Hamada HB, Bouji N +4

Europe PMC2025

ArticleKetamine

Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial.

Zheng X, Huang J, Wei S +6

Europe PMC2023